Related references
Note: Only part of the references are listed.Initiating Pharmacologic Treatment in Tobacco-Dependent Adults An Official American Thoracic Society Clinical Practice Guideline
Frank T. Leone et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Smoking and diabetes: dangerous liaisons and confusing relationships
D. Campagna et al.
DIABETOLOGY & METABOLIC SYNDROME (2019)
Secular trends in smoking in relation to prevalent and incident smoking-related disease: A prospective population based study
Philip Tonnesen et al.
TOBACCO INDUCED DISEASES (2019)
Interventions for smoking cessation in patients admitted with Acute Coronary Syndrome: a review
Omar M. Chehab et al.
POSTGRADUATE MEDICAL JOURNAL (2018)
Effects of varenicline therapy in combination with advanced behavioral support on smoking cessation and quality of life in inpatients with acute exacerbation of COPD, bronchial asthma, or community-acquired pneumonia: A prospective, open-labe preference-based, 52-week, follow-up trial
Alexios Politis et al.
CHRONIC RESPIRATORY DISEASE (2018)
Factors associated with the efficacy of smoking cessation treatments and predictors of smoking abstinence in EAGLES
Robert West et al.
ADDICTION (2018)
Weight gain after smoking cessation does not modify its protective effect on myocardial infarction and stroke: evidence from a cohort study of men
Kyuwoong Kim et al.
EUROPEAN HEART JOURNAL (2018)
Smoking Cessation, Weight Change, Type 2 Diabetes, and Mortality
Yang Hu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Jeffrey D. Stanaway et al.
LANCET (2018)
Varenicline in smokers with diabetes: A pooled analysis of 15 randomized, placebo-controlled studies of varenicline
Serena Tonstad et al.
JOURNAL OF DIABETES INVESTIGATION (2017)
Efficacy and Safety of Smoking Cessation Interventions in Patients With Cardiovascular Disease: A Network Meta-Analysis of Randomized Controlled Trials
Karine Suissa et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2017)
Varenicline for Smoking Cessation in Hospitalized Patients With Acute Coronary Syndrome
Mark J. Eisenberg et al.
CIRCULATION (2016)
EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries
Kornelia Kotseva et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2016)
Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial
Robert M. Anthenelli et al.
LANCET (2016)
Trends in tobacco use among US adults with chronic health conditions: National Survey on Drug Use and Health 2005-2013
Cassandra A. Stanton et al.
PREVENTIVE MEDICINE (2016)
Smoking cessation for people with chronic obstructive pulmonary disease
Eva A. M. van Eerd et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2016)
Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit
Carlos A. Jimenez-Ruiz et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
The effect of Varenicline on smoking cessation in a group of young asthma patients
Christian G. Westergaard et al.
RESPIRATORY MEDICINE (2015)
The association between smoking cessation and glycaemic control in patients with type 2 diabetes: a THIN database cohort study
Deborah Lycett et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
Systematic Review and Meta-Analysis of the Impact of Depression on Subsequent Smoking Cessation in Patients With Coronary Heart Disease: 1990 to 2013
Frank Doyle et al.
PSYCHOSOMATIC MEDICINE (2014)
Bupropion for Smoking Cessation in Patients Hospitalized With Cardiovascular Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Sonia M. Grandi et al.
CANADIAN JOURNAL OF CARDIOLOGY (2013)
Bupropion for Smoking Cessation in Patients Hospitalized With Acute Myocardial Infarction A Randomized, Placebo-Controlled Trial
Mark J. Eisenberg et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
21st-Century Hazards of Smoking and Benefits of Cessation in the United States
Prabhat Jha et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Smoking cessation and COPD
Philip Tonnesen
EUROPEAN RESPIRATORY REVIEW (2013)
Effects of Varenicline on Smoking Cessation in Patients With Mild to Moderate COPD A Randomized Controlled Trial
Donald P. Tashkin et al.
CHEST (2011)
Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Cardiovascular Disease A Randomized Trial
Nancy A. Rigotti et al.
CIRCULATION (2010)
Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation -: A randomized controlled trial
David Gonzales et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation -: A randomized controlled trial
Douglas E. Jorenby et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)